Unraveling the impact of sialic acids on the immune landscape and immunotherapy efficacy in pancreatic cancer

Abstract

Our results demonstrate that tumor-derived sialic acids mediate T-cell exclusion within the PDAC TME, thereby impairing immunotherapy efficacy. Targeting sialic acids represents a potential strategy to enhance T-cell infiltration and improve immunotherapy outcomes in PDAC.